Role of liver transplantation in human immunodeficiency virus positive patients

Table 3 Prospective studies conducted in human immunodeficiency virus/hepatitis C virus co-infected patients undergoing liver transplantation

	n	Patient survival	Incidence of ACR	Risk factors for death amongst HIV/HCV recipients1
Miro et al[65], 2012	HIV/HCV - 84	1, 3, 5 yr: 88%, 62%, 54%	38%	HCV G1
	HCV - 252	1, 3, 5 yr: 90%, 76%, 71%1	20%1	Donor risk index
				MELD score
				Center < 1 transplant/yr2
Terrault et al[66], 2012	HIV/HCV - 89	1 and 3 yr: 92% and 79%	39%	Combined liver-kidney transplant
	HCV - 235	1 and 3 yr: 76% and 60%1	24%1	BMI < 21
				Anti-HCV positive donor
				Older donor

¹Statistically significant (P < 0.05);

²Less than one liver transplant per year in a human immunodeficiency virus (HIV)-infected patient. HCV: Hepatitis C virus; BMI: Body mass index; ACR: Acute cellular rejection.